nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitope
|
Luria-Perez, R. |
|
2007 |
25 |
27 |
p. 5071-5085 15 p. |
artikel |
2 |
Antibody persistence following booster vaccination against tick-borne encephalitis: 3-Year post-booster follow-up
|
Rendi-Wagner, Pamela |
|
2007 |
25 |
27 |
p. 5097-5101 5 p. |
artikel |
3 |
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus
|
Yoshii, Hironori |
|
2007 |
25 |
27 |
p. 5006-5012 7 p. |
artikel |
4 |
Editorial Board
|
|
|
2007 |
25 |
27 |
p. CO2- 1 p. |
artikel |
5 |
Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP
|
Cao, Ju |
|
2007 |
25 |
27 |
p. 4996-5005 10 p. |
artikel |
6 |
Generation of long-lived plasma cells to serogroup B Neisseria meningitidis after murine immunisation with an outer membrane protein vaccine
|
Cruz, Simone C. |
|
2007 |
25 |
27 |
p. 5046-5052 7 p. |
artikel |
7 |
Human metapneumovirus: Enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged
|
Yim, Kevin C. |
|
2007 |
25 |
27 |
p. 5034-5040 7 p. |
artikel |
8 |
Imject® Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant
|
Hem, Stanley L. |
|
2007 |
25 |
27 |
p. 4985-4986 2 p. |
artikel |
9 |
Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state
|
Kim, Mikyung |
|
2007 |
25 |
27 |
p. 5102-5114 13 p. |
artikel |
10 |
Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein
|
Therrien, Roseline |
|
2007 |
25 |
27 |
p. 5053-5061 9 p. |
artikel |
11 |
Pre- or post-pandemic influenza vaccine?
|
Osterhaus, Albert D.M.E. |
|
2007 |
25 |
27 |
p. 4983-4984 2 p. |
artikel |
12 |
Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies
|
Przybylowski, Mark |
|
2007 |
25 |
27 |
p. 5013-5024 12 p. |
artikel |
13 |
Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case–control study in Nepalese children 5 years after immunization
|
Tandan, J.B. |
|
2007 |
25 |
27 |
p. 5041-5045 5 p. |
artikel |
14 |
Survey of poliovirus antibodies during the final stage of polio eradication in Egypt
|
El-Sayed, Nasr |
|
2007 |
25 |
27 |
p. 5062-5070 9 p. |
artikel |
15 |
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
|
Molinari, Noelle-Angelique M. |
|
2007 |
25 |
27 |
p. 5086-5096 11 p. |
artikel |
16 |
The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein
|
Sastre, Patricia |
|
2007 |
25 |
27 |
p. 5025-5033 9 p. |
artikel |
17 |
The use of vaccination to combat multiple introductions of Notifiable Avian Influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy
|
Capua, Ilaria |
|
2007 |
25 |
27 |
p. 4987-4995 9 p. |
artikel |